Quick Takeaways: Why It Matters? Jaguar’s NADA submission is a meaningful de-risking step for Canalevia-CA1, because full FDA approval would likely expand its commercial credibility beyond conditional use and make it easier to gain adoption in veterinary onc...
Quick Takeaways: Why It Matters? The commercial launch creates a multi-species, video-first monitoring layer that sits between home/owner observation and veterinary care, turning smartphones and connected cameras into continuous health sensors for pets, livestock, wildlife, and c...
Quick Takeaways: Why It Matters? Elanco is tightening its premium position in canine vaccines by launching the first 0.5 mL combo shot that covers both Lyme disease and leptospirosis in a single, low-volume dose, using its PureFil technology to support fewer reactions and more co...
Quick Takeaways: Why It Matters? Boehringer Ingelheim and Eko are turning every canine auscultation into a structured, AI‑backed cardiac assessment, using Eko Vet+ | CANINEBEAT AI to detect and grade heart murmurs with over 95% sensitivity and specificity against murmurs linked...
